Life Sciences |
|
 |
"Vitae Pharmaceuticals has been doing business with Oxford for many years. They are easy to deal with, offer better terms than their competitors, and we can always depend on them to do exactly what they say they are going to do. There are no surprises." Tina Fiumenero, Chief Financial Officer Vitae Pharmaceuticals |
 |
“Cadence Pharmaceuticals and the entire senior management team at Oxford have developed a comfortable and deep working relationship over the years. They’ve been very responsive to our financing requirements, and we can also count on them for timely execution.” William LaRue, Senior Vice President, Chief Financial Officer & Assistant Secretary Cadence Pharmaceuticals |
 |
“We selected Oxford for our venture loan because they have a strong reputation in the life sciences community and the best combination of terms. They’ve been in the market on a consistent basis; other lenders go in and out. Oxford’s people are always accessible and willing to work with us throughout all of our industry’s twists and turns.” John Beck, Senior Vice President, Finance & Operations & Chief Financial Officer Ardea Biosciences |
 |
"Oxford Finance has a solid reputation within our investor syndicate, and our experience with them was consistent with their reputation in the marketplace. Oxford took the time to develop a close business relationship, and the process for getting the deal done was seamless and fair." Todd Pope, President & Chief Executive Officer TransEnterix |
 |
“Of all the lending companies we spoke with, Oxford’s deal structure was the best fit for EUSA. They worked with us to resolve our issues and helped us meet our financial objectives. I found working with Oxford was a much more personal and open experience than dealing with a large bank.” David Cook, Chief Financial Officer EUSA Pharma |
 |
"Oxford offered our company the best overall deal terms. Since Oxford was the sole lender, the process was streamlined, and I had complete confidence in their ability to close the transaction quickly." |
 |
"Oxford has a great reputation in the financial community, and they were very willing to structure the deal to suit the needs of our company. They understand our business, and we know they will be there to work with us in both up and down markets." |
Healthcare Services |
|
 |
“Because Oxford has a solid understanding of the long term healthcare sector, their team could put together the right loan package with the structure and flexibility to help us grow our business. The chemistry was right between the principals, and the execution was timely and seamless.” Rowan Farber, President LifeHOUSE Health Services |
 |
“Our business was in need of financing in short order, so this was a very tough deal. Oxford focused on the right issues, hired the right attorney and flat out delivered—on time and on terms. We would recommend Oxford to any healthcare borrower." Joel Freedman, Principal CHHP Holdings II, LLC |
 |
“Throughout this complicated transaction, Oxford worked diligently and creatively to ensure our satisfaction with the terms. They delivered on both their promised financing amount and timeline." Donny Feldman, Senior Managing Director SnF Management |
 |
“We selected Oxford as our lender based on its reputation in the industry for being highly responsive and having a commitment to building long-term client relationships. We have a high comfort level with the team, and they clearly are aligned with our objective to grow our business.” Jack McGovern, Chief Executive Officer Comprehensive NeuroScience Care Management Technologies |
 |
"Oxford really understands the financing need of the senior housing industry. The company made it easy for us to navigate through the due diligence process, and the people we worked with have the sophistication, expertise and flexibility to craft the loan agreement to meet the unique needs of our company." John Bartle, Director Skyline Retirement Community |
